PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0029456|osteoporosis |
| Sentences | 10 |
| PubMedID- 25568651 | The prevalence of osteoporosis among patients with advanced chronic liver disease is reported between 12% and 55%; it is higher in primary biliary cirrhosis. |
| PubMedID- 21120296 | The presence of liver membrane antibodies, liver‐specific protein, and anti‐liver/kidney microsomal autoantibodies1 has permitted us to see that there may be some suspicious clues of autoimmune liver diseases in patients with osteoporosis as a secondary risk factor. |
| PubMedID- 23369371 | As far as we are aware, this is the first study to clinically evaluate the use of pre-treatment with ibandronate before lt. osteopenia and osteoporosis in patients with end-stage liver disease is a well known clinical problem, frequently associated with cholestatic diseases but also found in patients with hepatitis c, alcoholic liver disease and even hemochromatosis as reasons for lt[2,18]. |
| PubMedID- 21546334 | Management of osteoporosis in liver disease. |
| PubMedID- 21935455 | In addition chronic liver diseases are associated with co-morbidities like osteoporosis, protein and calorie malnutrition [39], which may cause increased co6-mmp levels originating from secondary tissues. |
| PubMedID- 23024865 | Hepatic osteodystrophy is defined as bone disease (osteomalacia, osteoporosis, and osteopenia) associated with liver disease. |
| PubMedID- 23269891 | Only a few small, randomized controlled studies of interventions for preventing osteoporosis and fractures in patients with chronic liver disease have been performed. |
| PubMedID- 21772972 | Osteopenia and osteoporosis are common complications of chronic liver disease. |
| PubMedID- 25972904 | Background: osteoporosis occurs frequently in patients with chronic cholestatic liver diseases, yet data are scarce regarding the prevalence of osteoporosis and fragility fractures and their impact on health-related quality of life (hrqol) in primary sclerosing cholangitis (psc). |
| PubMedID- 26418133 | Moreover, agt3, which can inhibit cytokine-like activity of ggt, may be a novel preventive/therapeutic agent for secondary osteoporosis in patients with chronic liver disease. |
Page: 1